A citation-based method for searching scientific literature

Christine Leopold, Anita K Wagner, Fang Zhang, Christine Y Lu, Craig Earle, Larissa Nekhlyudov, Dennis Ross-Degnan, J Frank Wharam. Breast Cancer Res Treat 2016
Times Cited: 6







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world setting.
Sara Hurvitz, Annie Guerin, Melissa Brammer, Ellie Guardino, Zheng-Yi Zhou, Dominick Latremouille Viau, Eric Q Wu, Deepa Lalla. Oncologist 2014
47
33


Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence.
Pawel Pludowski, Michael F Holick, Stefan Pilz, Carol L Wagner, Bruce W Hollis, William B Grant, Yehuda Shoenfeld, Elisabeth Lerchbaum, David J Llewellyn, Katharina Kienreich,[...]. Autoimmun Rev 2013
442
16

The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
Oluwole Fadare, Fattaneh A Tavassoli. Adv Anat Pathol 2007
63
16





Breast cancer treatment experiences by race and location in Georgia's Women's Health Medicaid Program.
Emily M Johnston, Sarah C Blake, Karen L Andes, Li-Nien Chien, E Kathleen Adams. Womens Health Issues 2014
7
16

The racial disparity in breast cancer mortality in the 25 largest cities in the United States.
Steven Whitman, Jennifer Orsi, Marc Hurlbert. Cancer Epidemiol 2012
46
16

Social determinants of Black-White disparities in breast cancer mortality: a review.
Mary A Gerend, Manacy Pai. Cancer Epidemiol Biomarkers Prev 2008
179
16

Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.
Reina Haque, Syed A Ahmed, Galina Inzhakova, Jiaxiao Shi, Chantal Avila, Jonathan Polikoff, Leslie Bernstein, Shelley M Enger, Michael F Press. Cancer Epidemiol Biomarkers Prev 2012
121
16

Differences in breast cancer stage, treatment, and survival by race and ethnicity.
Christopher I Li, Kathleen E Malone, Janet R Daling. Arch Intern Med 2003
507
16



Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Chad A Livasy, Gamze Karaca, Rita Nanda, Maria S Tretiakova, Olufunmilayo I Olopade, Dominic T Moore, Charles M Perou. Mod Pathol 2006
739
16

Disparities in breast cancer characteristics and outcomes by race/ethnicity.
Siew Loon Ooi, Maria Elena Martinez, Christopher I Li. Breast Cancer Res Treat 2011
190
16

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Martine J Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch,[...]. N Engl J Med 2005
16

Trends of socioeconomic disparities in referral patterns for fertility preservation consultation.
Linnea R Goodman, Ursula Balthazar, Jayeon Kim, Jennifer E Mersereau. Hum Reprod 2012
65
16

Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
Otto Metzger-Filho, Zhuoxin Sun, Giuseppe Viale, Karen N Price, Diana Crivellari, Raymond D Snyder, Richard D Gelber, Monica Castiglione-Gertsch, Alan S Coates, Aron Goldhirsch,[...]. J Clin Oncol 2013
185
16

Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.
Lisa A Newman, Kent A Griffith, Ismail Jatoi, Michael S Simon, Joseph P Crowe, Graham A Colditz. J Clin Oncol 2006
248
16



Triple-negative breast cancer: present challenges and new perspectives.
Franca Podo, Lutgarde M C Buydens, Hadassa Degani, Riet Hilhorst, Edda Klipp, Ingrid S Gribbestad, Sabine Van Huffel, Hanneke W M van Laarhoven, Jan Luts, Daniel Monleon,[...]. Mol Oncol 2010
192
16


Breast cancer survival in African-American women by hormone receptor subtypes.
Tomi Akinyemiju, Justin Xavier Moore, Sean F Altekruse. Breast Cancer Res Treat 2015
16
16

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.
Bhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae-You Kim,[...]. Breast Cancer Res 2011
142
16

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
Nils D Arvold, Alphonse G Taghian, Andrzej Niemierko, Rita F Abi Raad, Meera Sreedhara, Paul L Nguyen, Jennifer R Bellon, Julia S Wong, Barbara L Smith, Jay R Harris. J Clin Oncol 2011
270
16



Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.
Carol E DeSantis, Rebecca L Siegel, Ann Goding Sauer, Kimberly D Miller, Stacey A Fedewa, Kassandra I Alcaraz, Ahmedin Jemal. CA Cancer J Clin 2016
456
16

Triple-negative breast cancer in African-American women: disparities versus biology.
Eric C Dietze, Christopher Sistrunk, Gustavo Miranda-Carboni, Ruth O'Regan, Victoria L Seewaldt. Nat Rev Cancer 2015
199
16

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
16

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.
Abenaa M Brewster, Mariana Chavez-MacGregor, Powel Brown. Lancet Oncol 2014
123
16

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015
153
16


Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
51
16

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
L G Fulford, D F Easton, J S Reis-Filho, A Sofronis, C E Gillett, S R Lakhani, A Hanby. Histopathology 2006
243
16

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen K Chia, Charles M Perou, Torsten O Nielsen. Clin Cancer Res 2008
828
16


Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
16

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, Bernd Gerber, Wolfgang Eiermann, Jörn Hilfrich, Jens Huober,[...]. J Clin Oncol 2012
16

Heterogeneity in breast cancer.
Kornelia Polyak. J Clin Invest 2011
495
16

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Mary Jo Lund, Katrina F Trivers, Peggy L Porter, Ralph J Coates, Brian Leyland-Jones, Otis W Brawley, Elaine W Flagg, Ruth M O'Regan, Sheryl G A Gabram, J William Eley. Breast Cancer Res Treat 2009
265
16

Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Aleix Prat, Lisa A Carey, Barbara Adamo, Maria Vidal, Josep Tabernero, Javier Cortés, Joel S Parker, Charles M Perou, José Baselga. J Natl Cancer Inst 2014
117
16

Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.
Mary Jo Lund, Ebonee N Butler, Brionna Y Hair, Kevin C Ward, Judy H Andrews, Gabriella Oprea-Ilies, A Rana Bayakly, Ruth M O'Regan, Paula M Vertino, J William Eley. Cancer 2010
72
16

From molecular insight to therapeutic strategy: The holistic approach for treating triple negative breast cancer.
Rittwika Bhattacharya, Koyel Banerjee, Nupur Mukherjee, Minakshi Sen, Ashis Mukhopadhyay. Pathol Res Pract 2017
4
25

Economic, racial and ethnic disparities in breast cancer in the US: towards a more comprehensive model.
Richard T Campbell, Xue Li, Therese A Dolecek, Richard E Barrett, Kathryn E Weaver, Richard B Warnecke. Health Place 2009
37
16

Diagnosis and surgical delays in African American and white women with early-stage breast cancer.
Prethibha George, Sheenu Chandwani, Molly Gabel, Christine B Ambrosone, George Rhoads, Elisa V Bandera, Kitaw Demissie. J Womens Health (Larchmt) 2015
42
16

Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.
Gregory Vidal, Zoran Bursac, Gustavo Miranda-Carboni, Shelley White-Means, Athena Starlard-Davenport. Cancer Med 2017
14
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.